We introduced a myogenic differentiation system34 (link) into MELAS-iPSCs using a piggyBac vector, PB200_hMyoD,35 (link) including (Tet-On)-MYOD-IRES-EGFP cDNA and a neomycin resistance gene. A01 MELAS-iPSCs were transfected with a transposase-expressing plasmid, pHL-EF1a-hcPBase34 (link) (1.5 μg), and PB200-hMyoD (1.5 μg) using Nucleofector 2b (Lonza) and an Amaxa human stem cell Nucleofector kit 2 (Lonza), according to the manufacturer’s protocol, and were then plated on feeder cells. Forty-eight hours after the transfection, a G418 disulfate aqueous solution (50 μg/mL; Nacalai Tesque) was added to select appropriate MyoD-iPSC clones with high EGFP expression.
Free full text: Click here